VRDN
USDViridian Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$22.720
High
$23.050
Low
$22.140
Volume
4.98M
Company Fundamentals
Market Cap
2.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.03M
Exchange
NCM
Currency
USD
52-Week Range
Related News
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports
Related Stocks
ATRA
Atara Biotherapeutics Inc.
AWK
American Water Works Company Inc.
BHLB
Berkshire Hills Bancorp Inc.
BPOPM
Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities
FOF
Cohen & Steers Closed-End Opportunity Fund Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.